acetylcysteine

(redirected from Acetadote)
Also found in: Dictionary, Medical.
Related to Acetadote: Parvolex

acetylcysteine

[ə‚sed·əl′sis·tē‚ēn or ‚tēn]
(pharmacology)
HSCH2CH(NHCOCH3)COOH Crystals with a melting point of 109-110°C; used as a mucolytic drug.
References in periodicals archive ?
Acetadote, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury.
The US Court of Appeals for the Federal Circuit has ruled in favour of United States-based Cumberland Pharmaceuticals in a patent case associated with its Acetadote product, it was reported yesterday.
The advantages of Acetadote are that it's well tolerated and can be given in a 20- or 48-hour protocol, whereas oral NAC smells like rotten eggs and is approved as a 72-hour treatment regimen.
M2 PHARMA-January 8, 2013-Perrigo Company reports availability of authorised generic Acetadote Injection to prevent hepatic injury(C)2013 M2 COMMUNICATIONS
M2 EQUITYBITES-January 8, 2013-Perrigo Company reports availability of authorised generic Acetadote Injection to prevent hepatic injury(C)2013 M2 COMMUNICATIONS http://www.m2.com
M2 EQUITYBITES-November 8, 2012-Cumberland Pharmaceuticals Inc wins second Acetadote patent allowance with additional intellectual property protection through 2025(C)2012 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-November 8, 2012-Cumberland Pharmaceuticals Inc wins second Acetadote patent allowance with additional intellectual property protection through 2025(C)2012 M2 COMMUNICATIONS
M2 EQUITYBITES-February 29, 2012-Cumberland Pharmaceuticals enters into exclusive licensing agreement for Acetadote and Caldolor injectable products in China(C)2012 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-February 9, 2012-Cumberland Pharmaceuticals Inc receives Notice of Allowance for next generation Acetadote Injection(C)2012 M2 COMMUNICATIONS
Specialist pharmaceutical company Cumberland Pharmaceuticals Inc (Nasdaq:CPIX) revealed on Thursday the receipt of approval from the US Food and Drug Administration (FDA) for a new formulation of Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning.
M2 PHARMA-December 31, 2010-Cumberland voluntarily recalls 6 lots of Acetadote Injection(C)2010 M2 COMMUNICATIONS
M2 EQUITYBITES-December 31, 2010-Cumberland Pharmaceuticals voluntarily recalls six lots of Acetadote vials(C)2010 M2 COMMUNICATIONS http://www.m2.com